Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Bausch Health Companies Inc.
  6. News
  7. Summary
    BHC   CA0717341071

BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bausch Health Says Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference

01/11/2022 | 07:14am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BAUSCH HEALTH COMPANIES INC. 2.92% 9.86 Delayed Quote.-65.30%
ON SEMICONDUCTOR CORPORATION 5.49% 59.33 Delayed Quote.-17.20%
All news about BAUSCH HEALTH COMPANIES INC.
07:21aPiper Sandler Adjusts Bausch Health's Price Target to $7 From $27, Maintains Neutral Ra..
MT
05/24TRANSCRIPT : Bausch Health Companies Inc. Presents at Barclays Leveraged Finance Conferenc..
CI
05/24TRANSCRIPT : Bausch Health Companies Inc. Presents at Barclays High Yield Bond & Syndicate..
CI
05/24Bausch + Lomb Receives Health Canada Approval of Lumify Redness Reliever Eye Drops
MT
05/24BAUSCH + LOMB BRIEF : Receives Health Canada Approval of LUMIFY Redness Reliever Eye Drops
MT
05/24Bausch + Lomb Eye-Drop Product Gets Health Canada Approval
DJ
05/19Salix Pharmaceuticals To Share New Data At Digestive Disease Week 2022
AQ
05/18Bausch Health Says Salix Pharmaceuticals To Share New Data
MT
05/16Moody's Cuts Bausch Health's Senior Secured Ratings
MT
05/12TRANSCRIPT : Bausch Health Companies Inc. Presents at Goldman Sachs 7th Annual Leveraged F..
CI
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES INC.
More recommendations
Financials (USD)
Sales 2022 8 329 M - -
Net income 2022 -34,3 M - -
Net Debt 2022 19 398 M - -
P/E ratio 2022 -104x
Yield 2022 -
Capitalization 3 564 M 3 564 M -
EV / Sales 2022 2,76x
EV / Sales 2023 2,51x
Nbr of Employees 19 600
Free-Float 95,8%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | BHC | CA0717341071 | MarketScreener
Technical analysis trends BAUSCH HEALTH COMPANIES INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 9,86 $
Average target price 28,80 $
Spread / Average Target 192%
EPS Revisions
Managers and Directors
Robert N. Power Chief Executive Officer & Director
Thomas J. Appio President & Co-Head-Bausch Lomb International
Sam A. Eldessouky CFO, Chief Accounting Officer, SVP & Controller
Joseph C. Papa Chairman
Tage Ramakrishna Chief Medical Officer, President-R&D
Sector and Competitors
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC.-65.30%3 463
JOHNSON & JOHNSON5.00%472 652
PFIZER, INC.-9.04%301 361
ROCHE HOLDING AG-12.16%281 908
ELI LILLY AND COMPANY11.15%276 358
ABBVIE INC.12.23%268 530